Patents by Inventor William J. Rittman, III
William J. Rittman, III has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Publication number: 20200008975Abstract: A thermal therapy system includes at least one Peltier device having a heating side and a cooling side; a cold fluid channel adjacent the cooling side of the at least one Peltier device, and a hot fluid channel adjacent the heating side of the at least one Peltier device. A controllable cooling fluid pump in fluid communication with the cold fluid channel drives cooling fluid to an applicator pad, and an independently-controllable heating fluid pump in fluid communication with the hot fluid channel drives hot fluid to the applicator pad.Type: ApplicationFiled: June 26, 2019Publication date: January 9, 2020Inventors: William J. Rittman, III, Marsha Calise, Steven Woolfson
-
Patent number: 10350108Abstract: A thermal therapy system includes at least one Peltier device having a heating side and a cooling side; a cold fluid reservoir adjacent the cooling side of the Peltier device, and a hot fluid reservoir adjacent the heating side of the Peltier device. A controllable cooling fluid pump in fluid communication with the cold fluid reservoir drives cooling fluid to an applicator pad, and an independently-controllable heating fluid pump in fluid communication with the hot fluid reservoir drives hot fluid to the applicator pad.Type: GrantFiled: August 29, 2018Date of Patent: July 16, 2019Assignee: W&M Tech Advisors, LLCInventors: William J. Rittman, III, Marsha Calise, Steven Woolfson
-
Patent number: 8818503Abstract: A method and apparatus for diagnosing and treating neural dysfunction is disclosed. This device has the capability of delivering the therapeutic electrical energy to more than one treatment electrode simultaneously. In another exemplary embodiment, this device can perform EMG testing both before and after the therapeutic energy has been delivered, to assess whether the target nerve was successfully treated. In another embodiment, the device has the capability to record and store sensory stimulation thresholds both before and after treatment is described, which allows the clinician to accurately determine whether the target nerve has been desensitized. Energy control may achieved by simultaneously comparing the tip temperature of each treatment electrode to a set temperature selected by the operator, and regulating the therapeutic energy output to maintain the set temperature.Type: GrantFiled: August 30, 2013Date of Patent: August 26, 2014Assignee: NeuroTherm, Inc.Inventor: William J. Rittman, III
-
Publication number: 20140005747Abstract: A method and apparatus for diagnosing and treating neural dysfunction is disclosed. This device has the capability of delivering the therapeutic electrical energy to more than one treatment electrode simultaneously. In another exemplary embodiment, this device can perform EMG testing both before and after the therapeutic energy has been delivered, to assess whether the target nerve was successfully treated. In another embodiment, the device has the capability to record and store sensory stimulation thresholds both before and after treatment is described, which allows the clinician to accurately determine whether the target nerve has been desensitized. Energy control may achieved by simultaneously comparing the tip temperature of each treatment electrode to a set temperature selected by the operator, and regulating the therapeutic energy output to maintain the set temperature.Type: ApplicationFiled: August 30, 2013Publication date: January 2, 2014Applicant: NeuroTherm, Inc.Inventors: William J. Rittman, III, Howard Morgan Clarke
-
Patent number: 8560062Abstract: A method and apparatus for diagnosing and treating neural dysfunction is disclosed. This device has the capability of delivering the therapeutic electrical energy to more than one treatment electrode simultaneously. In another exemplary embodiment, this device can perform EMG testing both before and after the therapeutic energy has been delivered, to assess whether the target nerve was successfully treated. In another embodiment, the device has the capability to record and store sensory stimulation thresholds both before and after treatment is described, which allows the clinician to accurately determine whether the target nerve has been desensitized. Energy control may achieved by simultaneously comparing the tip temperature of each treatment electrode to a set temperature selected by the operator, and regulating the therapeutic energy output to maintain the set temperature.Type: GrantFiled: August 29, 2012Date of Patent: October 15, 2013Assignee: Neurotherm, Inc.Inventors: William J. Rittman, III, Howard Morgan Clarke
-
Publication number: 20130190846Abstract: A method and apparatus for diagnosing and treating neural dysfunction is disclosed. This device has the capability of delivering the therapeutic electrical energy to more than one treatment electrode simultaneously. In another exemplary embodiment, this device can perform EMG testing both before and after the therapeutic energy has been delivered, to assess whether the target nerve was successfully treated. In another embodiment, the device has the capability to record and store sensory stimulation thresholds both before and after treatment is described, which allows the clinician to accurately determine whether the target nerve has been desensitized. Energy control may achieved by simultaneously comparing the tip temperature of each treatment electrode to a set temperature selected by the operator, and regulating the therapeutic energy output to maintain the set temperature.Type: ApplicationFiled: August 29, 2012Publication date: July 25, 2013Applicant: NEUROTHERM, INC.Inventors: William J. Rittman, III, Howard Morgan Clarke
-
Patent number: 8265747Abstract: A method and apparatus for diagnosing and treating neural dysfunction is disclosed. This device has the capability of delivering the therapeutic electrical energy to more than one treatment electrode simultaneously. In another exemplary embodiment, this device can perform EMG testing both before and after the therapeutic energy has been delivered, to assess whether the target nerve was successfully treated. In another embodiment, the device has the capability to record and store sensory stimulation thresholds both before and after treatment is described, which allows the clinician to accurately determine whether the target nerve has been desensitized. Energy control may achieved by simultaneously comparing the tip temperature of each treatment electrode to a set temperature selected by the operator, and regulating the therapeutic energy output to maintain the set temperature.Type: GrantFiled: July 19, 2011Date of Patent: September 11, 2012Assignee: Neurotherm, Inc.Inventors: William J. Rittman, III, Howard Morgan Clarke
-
Publication number: 20120029592Abstract: A method and apparatus for diagnosing and treating neural dysfunction is disclosed. This device has the capability of delivering the therapeutic electrical energy to more than one treatment electrode simultaneously. In another exemplary embodiment, this device can perform EMG testing both before and after the therapeutic energy has been delivered, to assess whether the target nerve was successfully treated. In another embodiment, the device has the capability to record and store sensory stimulation thresholds both before and after treatment is described, which allows the clinician to accurately determine whether the target nerve has been desensitized. Energy control may achieved by simultaneously comparing the tip temperature of each treatment electrode to a set temperature selected by the operator, and regulating the therapeutic energy output to maintain the set temperature.Type: ApplicationFiled: July 19, 2011Publication date: February 2, 2012Applicant: NEUROTHERM, INC.Inventor: William J. Rittman, III
-
Publication number: 20120029420Abstract: A combined electrical and chemical stimulation lead is especially adapted for providing treatment to the spine and nervous system. The stimulation lead includes electrodes that may be selectively positioned along various portions of the stimulation lead in order to precisely direct electrical energy to ablate or electrically stimulate the target tissue. The invention also includes a method of activating electrodes in the electrical stimulation lead whereby an ablative lesion can be formed in a desired shape and size. The invention further includes a method of managing pain in a sacrum of a patient, and a method of assembling an electrical stimulation device.Type: ApplicationFiled: October 12, 2011Publication date: February 2, 2012Inventors: William J. Rittman, III, Bradley D. Vilims
-
Patent number: 8066702Abstract: A combined electrical and chemical stimulation lead is especially adapted for providing treatment to the spine and nervous system. The stimulation lead includes electrodes that may be selectively positioned along various portions of the stimulation lead in order to precisely direct electrical energy to ablate or electrically stimulate the target tissue. The invention also includes a method of activating electrodes in the electrical stimulation lead whereby an ablative lesion can be formed in a desired shape and size. The invention further includes a method of managing pain in a sacrum of a patient, and a method of assembling an electrical stimulation device.Type: GrantFiled: February 19, 2008Date of Patent: November 29, 2011Inventors: William J. Rittman, III, Bradley D. Vilims
-
Patent number: 8000785Abstract: A method and apparatus for diagnosing and treating neural dysfunction is disclosed. This device has the capability of delivering the therapeutic electrical energy to more than one treatment electrode simultaneously. In another exemplary embodiment, this device can perform EMG testing both before and after the therapeutic energy has been delivered, to assess whether the target nerve was successfully treated. In another embodiment, the device has the capability to record and store sensory stimulation thresholds both before and after treatment is described, which allows the clinician to accurately determine whether the target nerve has been desensitized. Energy control may achieved by simultaneously comparing the tip temperature of each treatment electrode to a set temperature selected by the operator, and regulating the therapeutic energy output to maintain the set temperature.Type: GrantFiled: December 13, 2010Date of Patent: August 16, 2011Assignee: NeuroTherm, Inc.Inventor: William J. Rittman, III
-
Publication number: 20110144634Abstract: A method and apparatus for diagnosing and treating neural dysfunction is disclosed. This device has the capability of delivering the therapeutic electrical energy to more than one treatment electrode simultaneously. In another exemplary embodiment, this device can perform EMG testing both before and after the therapeutic energy has been delivered, to assess whether the target nerve was successfully treated. In another embodiment, the device has the capability to record and store sensory stimulation thresholds both before and after treatment is described, which allows the clinician to accurately determine whether the target nerve has been desensitized. Energy control may achieved by simultaneously comparing the tip temperature of each treatment electrode to a set temperature selected by the operator, and regulating the therapeutic energy output to maintain the set temperature.Type: ApplicationFiled: December 13, 2010Publication date: June 16, 2011Applicant: NEUROTHERM, INC.Inventor: William J. Rittman, III
-
Patent number: 7853326Abstract: A method and apparatus for diagnosing and treating neural dysfunction is disclosed. This device has the capability of delivering the therapeutic electrical energy to more than one treatment electrode simultaneously. In another exemplary embodiment, this device can perform EMG testing both before and after the therapeutic energy has been delivered, to assess whether the target nerve was successfully treated. In another embodiment, the device has the capability to record and store sensory stimulation thresholds both before and after treatment is described, which allows the clinician to accurately determine whether the target nerve has been desensitized. Energy control may achieved by simultaneously comparing the tip temperature of each treatment electrode to a set temperature selected by the operator, and regulating the therapeutic energy output to maintain the set temperature.Type: GrantFiled: July 10, 2009Date of Patent: December 14, 2010Assignee: NeuroTherm, Inc.Inventor: William J. Rittman, III
-
Publication number: 20100016926Abstract: A method and apparatus for diagnosing and treating neural dysfunction is disclosed. This device has the capability of delivering the therapeutic electrical energy to more than one treatment electrode simultaneously. In another exemplary embodiment, this device can perform EMG testing both before and after the therapeutic energy has been delivered, to assess whether the target nerve was successfully treated. In another embodiment, the device has the capability to record and store sensory stimulation thresholds both before and after treatment is described, which allows the clinician to accurately determine whether the target nerve has been desensitized. Energy control may achieved by simultaneously comparing the tip temperature of each treatment electrode to a set temperature selected by the operator, and regulating the therapeutic energy output to maintain the set temperature.Type: ApplicationFiled: July 10, 2009Publication date: January 21, 2010Inventor: William J. Rittman, III
-
Publication number: 20090287140Abstract: An electrical stimulation and infusion introducer assembly is provided for connection to an electrical electrode/electrode. The electrode extends through the lumen of an introducer needle of the introducer assembly. The introducer assembly includes a side port for introduction of liquids through the introducer needle without having to remove the electrode. The side port communicates with the central passageway of the introducer assembly, and the central passageway in turn communicates with the lumen of the needle.Type: ApplicationFiled: May 16, 2008Publication date: November 19, 2009Inventor: William J. Rittman, III
-
Patent number: 7574257Abstract: A method and apparatus for diagnosing and treating neural dysfunction is disclosed. This device has the capability of delivering the therapeutic electrical energy to more than one treatment electrode simultaneously. In another exemplary embodiment, this device can perform EMG testing both before and after the therapeutic energy has been delivered, to assess whether the target nerve was successfully treated. In another embodiment, the device has the capability to record and store sensory stimulation thresholds both before and after treatment is described, which allows the clinician to accurately determine whether the target nerve has been desensitized. Energy control may achieved by simultaneously comparing the tip temperature of each treatment electrode to a set temperature selected by the operator, and regulating the therapeutic energy output to maintain the set temperature.Type: GrantFiled: August 2, 2006Date of Patent: August 11, 2009Assignee: NeuroTherm, Inc.Inventor: William J. Rittman, III
-
Patent number: 6692493Abstract: Relief of urethral obstruction is achieved by heat ablation of prostatic tissue by an ablation electrode passed within the urethra to a position in the prostate near the point of urethral obstruction. The electrode is coupled to a high frequency power supply to ablatively heat the urethra and the prostatic tissue near the urethra. Image guidance of the electrode placement is monitored by an imaging device. The temperature of the tissue is sensed at the electrode to control the high frequency heating energy and ablation process. The electrode has a blunt tip to help prevent piercing of the wall of the urethra during insertion of the electrode into the urethra through the penis and the positioning of the electrode tip near to the point of urethral obstruction. Several forms of electrodes, apparatus, and methods accommodate the specific objectives.Type: GrantFiled: August 26, 2002Date of Patent: February 17, 2004Assignees: Cosman Company, Inc., The General Hospital CorporationInventors: Francis J. McGovern, S. Nahum Goldberg, Eric R. Cosman, William J. Rittman, III
-
Patent number: 6575969Abstract: This patent application is a continuation-in-part of the patent application of the present authors related to target volume ablation in the body using a cooled-tip tissue-heating probe such as a fluid cooled (perfusion cooled) high frequency electrode. The present application relates in part to examples of specific embodiments of high frequency and radiofrequency electrode designs and heating and cooling system designs. It further describes embodiments in conjunction with 3-D or 2-D image data and computer graphic workstions to control, monitor, and pre-plan the process of target ablation. Specific examples of cooled-tip electrode constructions will be given which have utility for percutaneous or intraoperative cancerous tumor ablation. Cooled tip electrode systems with modular or separable components involving an insertion cannula, a radiofrequency electrode element, a cooling element, and a thermo-monitoring and/or radiofrequency connection electrode will be given.Type: GrantFiled: August 21, 2000Date of Patent: June 10, 2003Assignee: Sherwood Services AGInventors: William J. Rittman, III, Eric R. Cosman
-
Patent number: RE40279Abstract: A method and apparatus for altering a function of neural tissue in a patient. An electromagnetic signal is applied to the neural tissue through an electrode. The electromagnetic signal has a frequency component above the physiological stimulation frequency range and an intensity sufficient to produce an alteration of the neural tissue, the alteration causing the patient to experience a reduction in pain, and a waveform that prevents lethal temperature elevation of the neural tissue during application of the electromagnetic signal to the neural tissue.Type: GrantFiled: June 26, 1997Date of Patent: April 29, 2008Assignee: Sherwood Services AGInventors: Menno E. Sluijter, William J. Rittman, III, Eric R. Cosman
-
Patent number: RE41045Abstract: A method and apparatus for altering a function of neural tissue in a patient. An electromagnetic signal is applied to the neural tissue through an electrode. The electromagnetic signal has a frequency component above the physiological stimulation frequency range and an intensity sufficient to product an alteration of the neural tissue, the alteration causing the patient to experience a reduction in pain, and a waveform that prevents lethal temperature elecation of the neural tissue during application of the electromagnetic signal to the neural tissue.Type: GrantFiled: June 12, 2003Date of Patent: December 15, 2009Assignee: Covidien AGInventors: Menno E. Sluijter, William J. Rittman, III, Eric R. Cosman